Dosing Schedules and Administration of GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)
![Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis - The Lancet Global Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis - The Lancet Global](https://www.thelancet.com/cms/attachment/bec8df5d-3642-496f-b780-134bc21ac975/gr1_lrg.jpg)
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis - The Lancet Global
![Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial - Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial -](https://www.thelancet.com/cms/attachment/f470125a-7816-4234-aac2-7db9b5683965/gr1_lrg.jpg)
Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial -
![PDF] CE: Human papillomavirus (HPV) vaccine: Updated recommendations and strategies to improve Immunization Rates | Semantic Scholar PDF] CE: Human papillomavirus (HPV) vaccine: Updated recommendations and strategies to improve Immunization Rates | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/be04e680a4d2377ea20841ec1d38b6829c2b9e31/3-Table1-1.png)